Metabolic modulators following trauma sepsis: Sex hormones

Critical Care Medicine

Volumn 35, Issue 9 SUPPL., 2007, Pages

  Hsieh, Ya Ching ^a   Frink, Michael ^a   Choudhry, Mashkoor A ^a   Bland, Kirby I ^a   Chaudry, Irshad H ^a,b  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen receptors; Energy metabolism; Estrogen; Estrogen receptors; Hemorrhagic shock; Metabolic effects; Organ functions; Peroxisome proliferator activated receptor ; Peroxisome proliferator activated receptor ; Sepsis

Indexed keywords

ACUTE PHASE PROTEIN; ADENOSINE TRIPHOSPHATE; CYTOKINE; GLUCOSE; HORMONE RECEPTOR; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SEX HORMONE;

CONFERENCE PAPER; ENERGY METABOLISM; GENOMICS; GLUCOSE METABOLISM; HUMAN; INJURY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEX DIFFERENCE;

ACUTE-PHASE PROTEINS; ADENOSINE TRIPHOSPHATE; ANIMALS; CYTOKINES; ENERGY METABOLISM; FEMALE; GLUCOSE; GONADAL STEROID HORMONES; HUMANS; LIPID METABOLISM; MALE; MITOCHONDRIA; PPAR ALPHA; SEPSIS; SEX CHARACTERISTICS; WOUNDS AND INJURIES;

EID: 34548150238     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000278603.18687.4F     Document Type: Conference Paper

References (158)

1. World Health Organization: The World Health Report 1999 - Making a difference. Geneva, Switzerland, World Health Organization, 1999
2. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992; 268:3452-3455
3. Kher A, Wang M, Tsai BM, et al: Sex differences in the myocardial inflammatory response to acute injury. Shock 2005; 23:1-10
4. Hsieh YC, Choudhry MA, Yu HP, et al: Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J 2006; 20:1109-1117
5. Finnerty CC, Herndon DN, Chinkes DL, et al: Serum cytokine differences in severely burned children with and without sepsis. Shock 2007; 27:4-9
6. Choudhry MA, Schwacha MG, Hubbard WJ, et al: Gender differences in acute response to trauma-hemorrhage. Shock 2005; 24(Suppl 1):101-106
7. Hsieh YC, Yang S, Choudhry MA, et al: PGC-1 upregulation via estrogen receptors: A common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage. Am J Physiol Heart Circ Physiol 2005; 289:H2665-H-2672
8. Yokoyama Y, Schwacha MG, Samy TS, et al: Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002; 26:63-76
9. Angele MK, Schwacha MG, Ayala A, et al: Effect of gender and sex hormones on immune responses following shock. Shock 2000; 14:81-90
10. Baue AE: A debate on the subject "Are SIRS and MODS important entities in the clinical evaluation of patients?" The con position. Shock 2000; 14:590-593
11. Bruhn A, Verdant C, Vercruysse V, et al: Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis. Shock 2006; 26:169-173
12. Rossaint R, Cerny V, Coats TJ, et al: Key issues in advanced bleeding care in trauma. Shock 2006; 26:322-331
13. Tarnopolsky MA, Ruby BC: Sex differences in carbohydrate metabolism. Curr Opin Clin Nutr Metab Care 2001; 4:521-526
14. Blaak E: Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4:499-502
15. Hsieh YC, Yang S, Choudhry MA, et al: Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1. Am J Physiol Heart Circ Physiol 2006; 290:H416-H423
16. George RL, McGwin G Jr, Windham ST, et al: Age-related gender differential in outcome after blunt or penetrating trauma. Shock 2003; 19:28-32
17. Chaudry IH, Samy TS, Schwacha MG, et al: Endocrine targets in experimental shock. J Trauma 2003; 54:S118-S125
18. Hsieh YC, Yu HP, Suzuki T, et al: Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Cell Cardiol 2006; 41:511-521
19. Meldrum DR: Estrogen increases protective proteins following trauma and hemorrhage. Am J Physiol Regul Integr Comp Physiol 2006; 290:R809-R811
20. Yu HP, Hsieh YC, Suzuki T, et al: Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1004-L1009
21. Szalay L, Shimizu T, Schwacha MG, et al: Mechanism of salutary effects of estradiol on organ function after trauma-hemorrhage: Upregulation of heme oxygenase. Am J Physiol Heart Circ Physiol 2005; 289:H92-H98
22. Oberholzer A, Keel M, Zellweger R, et al: Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 2000; 48:932-937
23. Mostafa G, Huynh T, Sing RF, et al: Gender-related outcomes in trauma. J Trauma 2002; 53:430-434
24. Offner PJ, Moore EE, Biffl WL: Male gender is a risk factor for major infections after surgery. Arch Surg 1999; 134:935-938
25. Gannon CJ, Pasquale M, Tracy JK, et al: Male gender is associated with increased risk for postinjury pneumonia. Shock 2004; 21:410-414
26. Schroder J, Kahlke V, Staubach KH, et al: Gender differences in human sepsis. Arch Surg 1998; 133:1200-1205
27. Wichmann MW, Inthorn D, Andress HJ, et al: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26:167-172
28. George RL, McGwin G Jr, Metzger J, et al: The association between gender and mortality among trauma patients as modified by age. J Trauma 2003; 54:464-471
29. Wohltmann CD, Franklin GA, Boaz PW, et al: A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg 2001; 181:297-300
30. Napolitano LM, Greco ME, Rodriguez A, et al: Gender differences in adverse outcomes after blunt trauma. J Trauma 2001; 50:274-280
31. Eachempati SR, Hydo L, Barie PS: Genderbased differences in outcome in patients with sepsis. Arch Surg 1999; 134:1342-1347
32. Gannon CJ, Napolitano LM, Pasquale M, et al: A statewide population-based study of gender differences in trauma: Validation of a prior single-institution study. J Am Coll Surg 2002; 195:11-18
33. Jarrar D, Wang P, Knöferl MW, et al: Insight into the mechanism by which estradiol improves organ functions after traumahemorrhage. Surgery 2000; 128:246-252
34. Schneider CP, Nickel EA, Samy TS, et al: The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock 2000; 14:347-353
35. Wichmann MW, Zellweger R, DeMaso CM, et al: Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine 1996; 8:853-863
36. Angele MK, Knöferl MW, Schwacha MG, et al: Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol 1999; 277:C35-C42
37. Zellweger R, Wichmann MW, Ayala A, et al: Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997; 25:106-110
38. Yu HP, Yang S, Hsieh YC, et al: Maintenance of lung myeloperoxidase activity in proestrus females after trauma-hemorrhage: Upregulation of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol 2006; 291:L400-L406
39. Yang S, Choudhry MA, Hsieh YC, et al: Estrus cycle: Influence on cardiac function following trauma-hemorrhage. Am J Physiol Heart Circ Physiol 2006; 291:H2807-H2815
40. Samy TS, Zheng R, Matsutani T, et al: Mechanism for normal splenic T lymphocyte functions in proestrus females after trauma: Enhanced local synthesis of 17beta-estradiol. Am J Physiol Cell Physiol 2003; 285:C139-C149
41. Knöferl MW, Angele MK, Schwacha MG, et al: Immunoprotection in proestrus females following trauma-hemorrhage: The pivotal role of estrogen receptors. Cell Immunol 2003; 222:27-34
42. Horton JW, White DJ, Maass DL: Gender-related differences in myocardial inflammatory and contractile responses to major burn trauma. Am J Physiol Heart Circ Physiol 2004; 286:H202-H213
43. Jarrar D, Wang P, Cioffi WG, et al: The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol 2000; 279:H1015-H1021
44. Knöferl MW, Angele MK, Diodato MD, et al: Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg 2002; 235:105-112
45. Szalay L, Shimizu T, Suzuki T, et al: Estradiol improves cardiac and hepatic function after trauma-hemorrhage: Role of enhanced heat shock protein expression. Am J Physiol Regul Integr Comp Physiol 2006; 290:R812-R818
46. Kuebler JF, Jarrar D, Toth B, et al: Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 2002; 137:74-79
47. Kuebler JF, Jarrar D, Bland KI, et al: Progesterone administration after trauma and hemorrhagic shock improves cardiovascular responses. Crit Care Med 2003; 31:1786-1793
48. Ba ZF, Wang P, Koo DJ, et al: Testosterone receptor blockade after trauma and hemorrhage attenuates depressed adrenal function. Am J Physiol Regul Integr Comp Physiol 2000; 279:R1841-R1848
49. Remmers DE, Wang P, Cioffi WG, et al: Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol 1997; 273:H2919-H2925
50. Wichmann MW, Angele MK, Ayala A, et al: Flutamide: A novel agent for restoring the depressed cell-mediated immunity following soft-tissue trauma and hemorrhagic shock. Shock 1997; 8:242-248
51. Angele MK, Ayala A, Cioffi WG, et al: Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. Am J Physiol 1998; 274:C1530-C1536
52. Angele MK, Ayala A, Monfils BA, et al: Testosterone and/or low estradiol: Normally required but harmful immunologically for males after trauma-hemorrhage. J Trauma 1998; 44:78-85
53. Lloyd GW, Patel NR, McGing E, et al: Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart 2000; 84:189-192
54. Kawano H, Motoyama T, Ohgushi M, et al: Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 2001; 135:977-981
55. Clark PI, Glasser SP, Lyman GH, et al: Relation of results of exercise stress tests in young women to phases of the menstrual cycle. Am J Cardiol 1988; 61:197-199
56. Hubbard WJ, Bland KI, Chaudry IH: The role of the mitochondrion in trauma and shock. Shock 2004; 22:395-402
57. Taylor JH, Beilman GJ, Conroy MJ, et al: Tissue energetics as measured by nuclear magnetic resonance spectroscopy during hemorrhagic shock. Shock 2004; 21:58-64
58. Cairns CB, Moore FA, Haenel JB, et al: Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma. J Trauma 1997; 42:532-536
59. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497
60. Brealey D, Brand M, Hargreaves I, et al: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223
61. Sayeed MM: Mitochondrial dysfunction in sepsis: A familiar song with new lyrics. Crit Care Med 2002; 30:2780-2781
62. Fink MP: Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001; 17:219-237
63. 2. Surgery 1992; 112:150-158
64. 2 restores the depressed hepatocellular function and hepatic blood flow following hemorrhage and resuscitation. J Surg Res 1991; 50:368-374
65. 2 following trauma-hemorrhage and resuscitation: Downregulation of inflammatory cytokine (TNF, IL-6) release. J Surg Res 1992; 52:364-371
66. Masuda T, Sato K, Noda C, et al: Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 2003; 31:1987-1992
67. Brealey D, Singer M: Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 2003; 5:365-371
68. Chaudry IH: Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983; 245:R117-R134
69. Wang J, Green PS, Simpkins JW: Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 2001; 77:804-811
70. Fantappie MR, Galina A, Luis de Mendonca R, et al: Molecular characterization of a NADH ubiquinone oxidoreductase subunit 5 from Schistosoma mansoni and inhibition of mitochondrial respiratory chain function by testosterone. Mol Cell Biochem 1999; 202:149-158
71. Ripple MO, Hagopian K, Oberley TD, et al: Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxid Redox Signal 1999; 1:71-81
72. Hsieh YC, Frink M, Kawasaki T, et al: Down-regulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage. J Cell Physiol 2007; 211:364-370
73. Lehman JJ, Barger PM, Kovacs A, et al: Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000; 106:847-856
74. Wu Z, Puigserver P, Andersson U, et al: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98:115-124
75. Scarpulla RC: Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 2002; 1576:1-14
76. Scarpulla RC: Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002; 286:81-89
77. Chen JQ, Eshete M, Alworth WL, et al: Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J Cell Biochem 2004; 93:358-373
78. Chen JQ, Yager JD: Estrogen's effects on mitochondrial gene expression: Mechanisms and potential contributions to estrogen carcinogenesis. Ann N Y Acad Sci 2004; 1028:258-272
79. Stirone C, Duckles SP, Krause DN, et al: Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 2005; 68:959-965
80. Chen JQ, Yager JD, Russo J: Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta 2005; 1746:1-17
81. Chan SH, Wu KL, Wang LL, et al: Nitric oxide- and superoxide-dependent mitochondrial signaling in endotoxin-induced apoptosis in the rostral ventrolateral medulla of rats. Free Radic Biol Med 2005; 39:603-618
82. Wiener M, Rothkopf MM, Rothkopf G, et al: Fat metabolism in injury and stress. Crit Care Clin 1987; 3:25-56
83. White RH, Frayn KN, Little RA, et al: Hormonal and metabolic responses to glucose infusion in sepsis studied by the hyperglycemic glucose clamp technique. JPEN J Parenter Enteral Nutr 1987; 11:345-353
84. Wolfe RR, Shaw JH, Durkot MJ: Energy metabolism in trauma and sepsis: The role of fat. Prog Clin Biol Res 1983; 111:89-109
85. Campbell SE, Febbraio MA: Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am J Physiol Endocrinol Metab 2001; 281:E803-E808
86. Kamei Y, Suzuki M, Miyazaki H, et al: Ovariectomy in mice decreases lipid metabolism-related gene expression in adipose tissue and skeletal muscle with increased body fat. J Nutr Sci Vitaminol (Tokyo) 2005; 51:110-117
87. Taegtmeyer H: Energy metabolism of the heart: From basic concepts to clinical applications. Curr Probl Cardiol 1994; 19:59-113
88. Faddy HM, Robinson JA, Lee WJ, et al: Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate. Int J Biochem Cell Biol 2006; 38:255-266
89. Campbell SE, Mehan KA, Tunstall RJ, et al: 17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. J Mol Endocrinol 2003; 31:37-45
90. Yue TL, Bao W, Jucker BM, et al: Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury. Circulation 2003; 108:2393-2399
91. Cuzzocrea S, Di Paola R, Mazzon E, et al: WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 2004; 22:340-346
92. Duval C, Chinetti G, Trottein F, et al: The role of PPARs in atherosclerosis. Trends Mol Med 2002; 8:422-430
93. van Raalte DH, Li M, Pritchard PH, et al: Peroxisome proliferator- activated receptor (PPAR)-alpha: A pharmacological target with a promising future. Pharm Res 2004; 21:1531-1538
94. Erol E, Kumar LS, Cline GW, et al: Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J 2004; 18:347-349
95. Stahlberg N, Rico-Bautista E, Fisher RM, et al: Female-predominant expression of fatty acid translocase/CD36 in rat and human liver. Endocrinology 2004; 145:1972-1979
96. Kiens B, Roepstorff C, Glatz JF, et al: Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: Influence of physical activity and gender. J Appl Physiol 2004; 97:1209-1218
97. Heuer JG, Sharma GR, Zhang T, et al: Effects of hyperglycemia and insulin therapy on outcome in a hyperglycemic septic model of critical illness. J Trauma 2006; 60:865-872
98. Vogelzang M, Nijboer JM, van der Horst IC, et al: Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Trauma 2006; 60:873-877
99. Rusavy Z, Macdonald IA, Sramek V, et al: Glycemia influences on glucose metabolism in sepsis during hyperinsulinemic clamp. JPEN J Parenter Enteral Nutr 2005; 29:171-175
100. Gore DC, Chinkes D, Heggers J, et al: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-544
101. Lange MP, Dahn MS, Jacobs LA: The significance of hyperglycemia after injury. Heart Lung 1985; 14:470-472
102. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367
103. Chiolero R, Revelly JP, Tappy L: Energy metabolism in sepsis and injury. Nutrition 1997; 13:45S-51S
104. Hart CD, Flozak AS, Simmons RA: Modulation of glucose transport in fetal rat lung: A sexual dimorphism. Am J Respir Cell Mol Biol 1998; 19:63-70
105. Chisari AN, Gaillard RC, Giovambattista A, et al: Sexual dimorphism in the hypothalamo-pituitary-adrenal (HPA) axis and TNFalpha responses to phospholipase A2-related neurotoxin (from crotalus durissus terrifcus) challenge. J Endocrinol Invest 2000; 23:440-448
106. Carrington LJ, Bailey CJ: Effects of natural and synthetic estrogens and progestins on glycogen deposition in female mice. Horm Res 1985; 21:199-203
107. Campbell SE, Febbraio MA: Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 2002; 282:E1139-E1146
108. Barros RP, Machado UF, Warner M, et al: Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci U S A 2006; 103:1605-1608
109. Stephens JM, Bagby GJ, Pekala PH, et al: Differential regulation of glucose transporter gene expression in adipose tissue or septic rats. Biochem Biophys Res Commun 1992; 183:417-422
110. Gonzalez CG, Garcia FD, Fernandez SF, et al: Role of 17Beta-estradiol and progesterone on glucose homeostasis: Effects of food restriction (50%) in pregnant and nonpregnant rats. J Endocrinol Invest 1997; 20:397-403
111. Patten RD, Pourati I, Aronovitz MJ, et al: 17Beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004; 95:692-699
112. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM: Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: Relevance in cell proliferation. Int J Cancer 2004; 109:167-173
113. Hunter JC, Kostyak JC, Novotny JL, et al: Estrogen deficiency decreases ischemic tolerance in aged rat myocardium: Roles of PKCdelta, PKCepsilon, Akt, and GSK3beta. Am J Physiol Regul Integr Comp Physiol 2007; 292:R800-R809
114. Sakoda H, Gotoh Y, Katagiri H, et al: Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 2003; 278:25802-25807
115. Williams DL, Ozment-Skelton T, Li C: Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006; 25:432-439
116. Vary TC, Deiter G, Kimball SR: Phosphorylation of eukaryotic initiation factor eIF2Bepsilon in skeletal muscle during sepsis. Am J Physiol Endocrinol Metab 2002; 283:E1032-E1039
117. Rennie MJ: Muscle protein turnover and the wasting due to injury and disease. Br Med Bull 1985; 41:257-264
118. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792
119. Moshage H: Cytokines and the hepatic acute phase response. J Pathol 1997; 181:257-266
120. Uzzan B, Cohen R, Nicolas P, et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003
121. Beigneux AP, Moser AH, Shigenaga JK, et al: The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 2000; 275:16390-16399
122. Livingston DH, Mosenthal AC, Deitch EA: Sepsis and multiple organ dysfunction syndrome: A clinical-mechanistic overview. New Horiz 1995; 3:257-266
123. Selzman CH, Shames BD, Miller SA, et al: Therapeutic implications of interleukin-10 in surgical disease. Shock 1998; 10:309-318
124. Tracey KJ, Fong Y, Hesse DG, et al: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664
125. Gao H, Liang M, Bergdahl A, et al: Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells. Inflamm Res 2006; 55:349-353
126. Bell SC: Effects of oestradiol and progesterone on the concentration of alpha 2-macroglobulin in the sera of injured male and female rats. J Endocrinol 1980; 86:189-191
127. Wang D, Oparil S, Chen YF, et al: Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol 2005; 25:2094-2099
128. Jeschke MG, Barrow RE, Mlcak RP, et al: Endogenous anabolic hormones and hypermetabolism: Effect of trauma and gender differences. Ann Surg 2005; 241:759-767
129. Lakoski SG, Brosnihan B, Herrington DM: Hormone therapy, C-reactive protein, and progression of atherosclerosis: Data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial. Am Heart J 2005; 150:907-911
130. Yang SX, Diaz Padilla N, Zhu Q, et al: Estrogen replacement raises rat CRP without evidence of complement activation. Endocr Res 2005; 31:121-132
131. Yu HP, Choudhry MA, Shimizu T, et al: Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: Upregulation of estrogen receptor-{beta}-dependent HO-1. J Leukoc Biol 2006; 79:277-284
132. Kuiper GG, Carlsson B, Grandien K, et al: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138:863-870
133. Meyers MJ, Sun J, Carlson KE, et al: Estrogen receptor-beta potency-selective ligands: Structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 2001; 44:4230-4251
134. Suzuki T, Shimizu T, Yu HP, et al: A selective estrogen receptor-alpha agonist reduces hepatic injury following traumahemorrhage. Abstr. Shock 2005; 23:abstract 83
135. Yu HP, Shimizu T, Hsieh YC, et al: Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage. J Leukoc Biol 2006; 79:963-970
136. Yu HP, Shimizu T, Choudhry MA, et al: Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: Up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 2006; 40:185-194
137. Hildebrand F, Hubbard WJ, Choudhry MA, et al: Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha or ER-beta? J Leukoc Biol 2006; 79:1173-1180
138. Suzuki T, Shimizu T, Yu HP, et al: Tissue-compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage. J Appl Physiol 2007; 102:163-168
139. Kuiper GG, Enmark E, Pelto-Huikko M, et al: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996; 93:5925-5930
140. Olsen NJ, Kovacs WJ: Effects of androgens on T and B lymphocyte development. Immunol Res 2001; 23:281-288
141. Landers JP, Spelsberg TC: New concepts in steroid hormone action: Transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr 1992; 2:19-63
142. Simoncini T, Genazzani AR: Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003; 148:281-292
143. Ho KJ, Liao JK: Nonnuclear actions of estrogen. Arterioscler Thromb Vasc Biol 2002; 22:1952-1961
144. Vicencio JM, Ibarra C, Estrada M, et al: Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 2006; 147:1386-1395
145. Tcherepanova I, Puigserver P, Norris JD, et al: Modulation of estrogen receptoralpha transcriptional activity by the coactivator PGC-1. J Biol Chem 2000; 275:16302-16308
146. Knowlton AA, Sun L: Heat-shock factor-1, steroid hormones, and regulation of heatshock protein expression in the heart. Am J Physiol Heart Circ Physiol 2001; 280:H455-H464
147. Ikejima K, Enomoto N, Iimuro Y, et al: Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 1998; 274:G669-G676
148. Ba ZF, Shimizu T, Szalay L, et al: Gender differences in small intestinal perfusion following trauma hemorrhage: The role of endothelin-1. Am J Physiol Gastrointest Liver Physiol 2005; 288:G860-G865
149. Razandi M, Pedram A, Greene GL, et al: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 1999; 13:307-319
150. Revankar CM, Cimino DF, Sklar LA, et al: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307:1625-1630
151. Toran-Allerand CD, Guan X, MacLusky NJ, et al: ER-X: A novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 2002; 22:8391-8401
152. Kow LM, Pfaff DW: The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions. Proc Natl Acad Sci U S A 2004; 101:12354-12357
153. Hsieh YC, Yu HP, Frink M, et al: G Protein-coupled receptor 30-dependent protein kinase A pathway is critical in non-genomic effects of estrogen in attenuating liver injury after trauma. Am J Pathol 2007; 170:1210-1218
154. Yu HP, Hsieh YC, Suzuki T, et al: The PI3K/AKT pathway mediates the nongenomic cardioprotection effects of estrogen following trauma-hemorrhage. Ann Surg 2007; 245:971-977
155. Chen DB, Bird IM, Zheng J, et al: Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004; 145:113-125
156. Carrer HF, Cambiasso MJ, Gorosito S: Effects of estrogen on neuronal growth and differentiation. J Steroid Biochem Mol Biol 2005; 93:319-323
157. Suzuki T, Shimizu T, Yu HP, et al: 17betaestradiol administration following traumahemorrhage prevents the increase in Kupffer cell cytokine production and MAPK activation predominately via estrogen receptor-alpha. Surgery 2006; 140:141-148
158. Angele MK, Nitsch S, Knöferl MW, et al: Sex-specific p38 MAP kinase activation following trauma-hemorrhage: Involvement of testosterone and estradiol. Am J Physiol Endocrinol Metab 2003; 285:E189-E196